Extensive Disease Small Cell Lung Cancer And High Slfn11 Expression clinical trials

Explore recruiting extensive disease small cell lung cancer and high slfn11 expression clinical trials.

Also recruiting in Europe

Extensive Disease Small Cell Lung Cancer And High Slfn11 Expression trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

ETOP 23-22 RAISE: A single-arm phase II study of the addition of niraparib to anti-PD-L1 antibody maintenance in patients with SLFN11-positive, extensive-disease small cell lung cancer.

Spain, France, Italy, Romania, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Extensive Disease Small Cell Lung Cancer And High Slfn11 Expression trials by city

Extensive Disease Small Cell Lung Cancer And High Slfn11 Expression in Toronto Extensive Disease Small Cell Lung Cancer And High Slfn11 Expression in Vancouver Extensive Disease Small Cell Lung Cancer And High Slfn11 Expression in Montreal Extensive Disease Small Cell Lung Cancer And High Slfn11 Expression in Calgary Extensive Disease Small Cell Lung Cancer And High Slfn11 Expression in Edmonton Extensive Disease Small Cell Lung Cancer And High Slfn11 Expression in Ottawa Extensive Disease Small Cell Lung Cancer And High Slfn11 Expression in Winnipeg Extensive Disease Small Cell Lung Cancer And High Slfn11 Expression in Quebec City Extensive Disease Small Cell Lung Cancer And High Slfn11 Expression in Hamilton Extensive Disease Small Cell Lung Cancer And High Slfn11 Expression in Kitchener Extensive Disease Small Cell Lung Cancer And High Slfn11 Expression in London Extensive Disease Small Cell Lung Cancer And High Slfn11 Expression in Halifax Extensive Disease Small Cell Lung Cancer And High Slfn11 Expression in New York Extensive Disease Small Cell Lung Cancer And High Slfn11 Expression in Los Angeles Extensive Disease Small Cell Lung Cancer And High Slfn11 Expression in Chicago Extensive Disease Small Cell Lung Cancer And High Slfn11 Expression in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease